-
TIME
TOPIC
Sunday, June 15, 2025
-
12:00 – 13:00
Registration
-
13:00 – 13:30
Opening Remark - Cross-border Licensing Trends
Speaker:
David Chen, Managing Director, BFC Group
-
13:30 – 14:00
Keynote Speech – Navigating Challenges in Quickly Shifting Landscapes: Strategic Partnering and Cross-Border Transactions in Life Sciences
Speaker:
Henry He, Partner, Fangda Partners
-
14:00 – 14:30
Coffee Break
-
14:30 – 15:30
Panel 1 – Biopharma Investment Landscape: What’s Driving Deals in 2025 and Beyond?
Speaker:
Michael Tung, MD, Chief Financial Officer, vTv Therapeutics
Distinguished Speakers:
Grace Han McMahon, Associate Vice President and Head, Pacific Business Development & Licensing, MSD
Venkatesan Raghavan, Executive Director Search & Evaluation – Oncology, Novartis
Tomohiro Yamauchi, Executive Director, Global Head of Scouting & Transaction Oncology, Astellas
Johan Verbeeck, Vice President Business Development, Oncology, Johnson & Johnson Innovative Medicine
Toby Freyman, Vice President, Business Development, Alexion Pharmaceuticals
-
15:30 – 15:45
Coffee Break
-
15:45 – 16:45
Panel 2 - Maximizing Global Value from Asia’s Early-Stage Biotech Innovation
Moderator:
Mitchell Zhang, Vice President, BFC Group
Distinguished Speakers:
Maha Radhakrishnan, Executive Partner, Sofinnova Investments
Christopher Hupp, Senior Director, External Innovation, Chemistry, Ipsen
Harish Soundararajan, Vice President, Roivant Sciences
Dan Zheng, Senior Director for Oncology Business Development，Center for External Innovation, Takeda
Tess Cameron, Principal, RA Capital
-
16:45 – 17:45
Panel 3 - The Rise of China Biotech: Why Global Pharma is Betting Big?
Moderator:
Yuan Mi, Founder/COO, CytosinLab Therapeutics
Distinguished Speakers:
Cynthia Wang, Director, Global Business Development, Asia-Pacific Region, Servier
Josh Shin, Partner, Fangda Partners
Guoxin Zhu, Vice President, Molecule Discovery, Lilly Research Laboratories, Eli Lilly and Company
René Fuertig, Global Head of Neuroscience & Mental Health BD+L, Boehringer Ingelheim
Adrianne L.Wong, Director, Oncology Search & Evaluation of Global Business Development,Daiichi Sankyo
